Novel adenoviral serotype 5 based immunotherapeutic induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Morse, M; Gabitzsch, E; Balint, JP; Xu, Y; Lyerly, HK; Jones, F

Published Date

  • January 2013

Published In

Volume / Issue

  • 1 / Suppl 1

Start / End Page

  • P129 - P129

Pubmed Central ID

  • PMC:PMC3991371

Electronic International Standard Serial Number (EISSN)

  • 2051-1426

International Standard Serial Number (ISSN)

  • 2051-1426

Digital Object Identifier (DOI)

  • 10.1186/2051-1426-1-S1-P129

Language

  • eng